Literature DB >> 12503890

Cyclooxygenase (COX)-2 and granulosa cell apoptosis in vitro.

Angela S Caffrey1, William C Patton, Johannah U Corselli, Ron E Swensen, Alan King, Philip J Chan.   

Abstract

PURPOSE: C-myc was studied in cyclooxygenase (COX)-2 associated granulosa cell apoptosis,
METHODS: Granulosa cells (N = 5 cases) were incubated for 24 h in either 1 or 50 microM COX-2 inhibitor, 1 or 50 microM COX-1/COX-2 inhibitor, negative or positive controls Single primer polymerase chain reaction of c-myc exon 1 were performed. Bisbenzimide-stained control single-stranded (ssDNA) were hybridized to SYBR Gold-stained ssDNA and fluorescent images analyzed.
RESULTS: C-myc was disrupted by the high-dose COX-2 inhibitor. Cell viability decreased with COX-1 and COX-2 inhibition. However, cell viability was similar for the positive control and at low-dose COX-2 inhibition.
CONCLUSIONS: Inhibition of both COX-1 and COX-2 initiated apoptosis without disrupting c-myc suggesting a protective effect on c-myc. The low dosage of the COX-2 inhibitor did not disrupt c-myc and cell viability. C-myc sensitization was not part of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503890      PMCID: PMC3455834          DOI: 10.1023/a:1021215216246

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  30 in total

1.  Myc requires distinct E2F activities to induce S phase and apoptosis.

Authors:  G Leone; R Sears; E Huang; R Rempel; F Nuckolls; C H Park; P Giangrande; L Wu; H I Saavedra; S J Field; M A Thompson; H Yang; Y Fujiwara; M E Greenberg; S Orkin; C Smith; J R Nevins
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

2.  c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle.

Authors:  S Adachi; A J Obaya; Z Han; N Ramos-Desimone; J H Wyche; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

3.  Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice.

Authors:  J Reese; X Zhao; W G Ma; N Brown; T J Maziasz; S K Dey
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

4.  Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.

Authors:  K Uefuji; T Ichikura; N Shinomiya; H Mochizuki
Journal:  Anticancer Res       Date:  2000 Nov-Dec       Impact factor: 2.480

5.  The effects of an inhibitor of prostaglandin synthesis (indomethacin) on ovulation, pregnancy, and pseudopregnancy in the rabbit.

Authors:  J P O'Grady; B V Caldwell; F J Auletta; L Speroff
Journal:  Prostaglandins       Date:  1972-02

6.  A simple DNA disc chip in a microarray design based on modified comparative genomic hybridization for sperm DNA analysis.

Authors:  Philip J Chan; Sylvia L Mann; Johannah U Corselli; William C Patton; Alan King; John D Jacobson
Journal:  Fertil Steril       Date:  2002-05       Impact factor: 7.329

7.  Stimulated release of arachidonic acid from rat liver cells by celecoxib and indomethacin.

Authors:  L Levine
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2001-07       Impact factor: 4.006

8.  A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line.

Authors:  R Supino; P Perego; L Gatti; C Caserini; C Leonetti; M Colantuono; V Zuco; N Carenini; G Zupi; F Zunino
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

9.  Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.

Authors:  C S Williams; A J Watson; H Sheng; R Helou; J Shao; R N DuBois
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

10.  Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

Authors:  M Tsujii; S Kawano; S Tsuji; H Sawaoka; M Hori; R N DuBois
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.